Solara’s Mangalore Site Clears US FDA Inspection with VAI Status
POWER & RENEWABLE ENERGY

Solara’s Mangalore Site Clears US FDA Inspection with VAI Status

Solara Active Pharma Sciences has announced the successful completion of the US Food and Drug Administration (US FDA) inspection at its multi-product Active Pharmaceutical Ingredient manufacturing facility in Mangalore, Karnataka. The inspection, conducted from 25 to 29 August 2025, concluded with the issuance of an Establishment Inspection Report (EIR) on 18 November 2025. The Agency classified the facility as “Voluntary Action Indicated” (VAI), confirming continued compliance with current Good Manufacturing Practices (cGMP) and formally closing the inspection.

According to the company, the US FDA issued two procedural Form 483 observations at the end of the inspection. Solara submitted a comprehensive response within the stipulated timeframe, following which the Agency acknowledged the adequacy of the corrective actions and closed the inspection. The company noted that the outcome reflects its commitment to regulatory excellence, robust quality systems and adherence to global compliance standards across all manufacturing sites.

The Mangalore facility is equipped with multiple independent production blocks and packaging units, enabling supply of a wide portfolio of APIs. It is also regularly inspected by leading global regulatory bodies, including EDQM, HPRA, TGA, WHO, PMDA and MFDS Korea. Solara stated that maintaining world-class quality and compliance remains central to its long-term growth strategy.

Solara Active Pharma Sciences has announced the successful completion of the US Food and Drug Administration (US FDA) inspection at its multi-product Active Pharmaceutical Ingredient manufacturing facility in Mangalore, Karnataka. The inspection, conducted from 25 to 29 August 2025, concluded with the issuance of an Establishment Inspection Report (EIR) on 18 November 2025. The Agency classified the facility as “Voluntary Action Indicated” (VAI), confirming continued compliance with current Good Manufacturing Practices (cGMP) and formally closing the inspection. According to the company, the US FDA issued two procedural Form 483 observations at the end of the inspection. Solara submitted a comprehensive response within the stipulated timeframe, following which the Agency acknowledged the adequacy of the corrective actions and closed the inspection. The company noted that the outcome reflects its commitment to regulatory excellence, robust quality systems and adherence to global compliance standards across all manufacturing sites. The Mangalore facility is equipped with multiple independent production blocks and packaging units, enabling supply of a wide portfolio of APIs. It is also regularly inspected by leading global regulatory bodies, including EDQM, HPRA, TGA, WHO, PMDA and MFDS Korea. Solara stated that maintaining world-class quality and compliance remains central to its long-term growth strategy.

Next Story
Infrastructure Urban

Centre Pushes Faster PSP Development At Pinnapuram Meeting

The Ministry of Power convened a meeting of its Consultative Committee of Members of Parliament at Pinnapuram in Kurnool district, Andhra Pradesh, focusing on the growing importance of Pumped Storage Projects (PSPs). The session was chaired by Union Minister of Power Shri Manohar Lal, and attended by Minister of State for Power Shri Shripad Yesso Naik, MPs from both Houses, and senior officials from the Ministry of Power, the Central Electricity Authority (CEA) and Central Public Sector Undertakings. Shri Manohar Lal emphasised that PSPs are crucial for storing surplus green power and supplyi..

Next Story
Infrastructure Urban

GSV, DRDO Partner To Develop New Defence Tech Solutions

Gati Shakti Vishwavidyalaya (GSV) and the Defence Research and Development Organisation (DRDO) have signed a Memorandum of Understanding in New Delhi on 17 November 2025 in the presence of Dr Samir V. Kamat, Chairman of DRDO and Secretary of Defence R&D. The partnership aims to develop smart technological solutions to enhance national security. Dr Kamat stated that the collaboration is expected to support the development of technological solutions for the deployment aspects of indigenous defence systems. Under the MoU, both organisations will undertake joint studies and research in areas suc..

Next Story
Infrastructure Energy

PVV Infra To Build Rs6.5 Billion Solar Cell Plant In Andhra Pradesh

PVV Infra Ltd., a company engaged in solar rooftop installations, has signed a Memorandum of Understanding with the Andhra Pradesh Economic Development Board to establish a solar cells manufacturing facility in the State. The project represents an investment of Rs6.5 billion. The new manufacturing unit will be set up in Visakhapatnam, near the airport, on a 30-acre industrial site within the region’s solar cells manufacturing cluster. According to the company, the development is expected to generate around 350 direct jobs and more than 450 indirect jobs. PVV Infra stated that it will draw ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement